ホーム>>Signaling Pathways>> Membrane Transporter/Ion Channel>> P2X purinergic receptor>>PSB-12062 (N-(p-Methylphenylsulfonyl)phenoxazine)

PSB-12062 (N-(p-Methylphenylsulfonyl)phenoxazine) (Synonyms: N-(p-Methylphenylsulfonyl)phenoxazine)

カタログ番号GC30805

PSB-12062 (N-(p-メチルフェニルスルホニル)フェノキサジン) は、ヒト P2X4 に対して 1.38 μM の IC50 を持つ強力で選択的な P2X4 アンタゴニストです。

Products are for research use only. Not for human use. We do not sell to patients.

PSB-12062 (N-(p-Methylphenylsulfonyl)phenoxazine) 化学構造

Cas No.: 55476-47-6

サイズ 価格 在庫数 個数
10mM (in 1mL DMSO)
$61.00
在庫あり
5mg
$56.00
在庫あり
10mg
$82.00
在庫あり
25mg
$179.00
在庫あり
50mg
$321.00
在庫あり
100mg
$579.00
在庫あり

Tel:(909) 407-4943 Email: sales@glpbio.com

顧客レビュー

カスタマーレビューに基づきます。

  • GlpBio Citations

    GlpBio Citations
  • Bioactive Compounds Premium Provider

    Bioactive Compounds Premium Provider

Sample solution is provided at 25 µL, 10mM.

Description Protocol Chemical Properties Product Documents Related Products

PSB-12062 is a potent and selective P2X4 antagonist with an IC50 of 1.38 μM for human P2X4.

PSB-12062 shows similar potency in human, rat, and mouse species. PSB-12062 shows to be allosteric in nature with a 35-fold selectivity toward P2X4 versus P2X1, P2X2, P2X3, and P2X7. However, PSB-12062 is unable to completely block ATP-induced P2X4-mediated calcium influx even when used at high concentrations (>30 μM)[1].

[1]. Hernandez-Olmos V, et al. N-substituted phenoxazine and acridone derivatives: structure-activity relationships of potent P2X4 receptor antagonists. J Med Chem. 2012 Nov 26;55(22):9576-88. [2]. Stokes L, et al. P2X4 Receptor Function in the Nervous System and Current Breakthroughs in Pharmacology.Front Pharmacol. 2017 May 23;8:291.

レビュー

Review for PSB-12062 (N-(p-Methylphenylsulfonyl)phenoxazine)

Average Rating: 5 ★★★★★ (Based on Reviews and 5 reference(s) in Google Scholar.)

5 Star
100%
4 Star
0%
3 Star
0%
2 Star
0%
1 Star
0%
Review for PSB-12062 (N-(p-Methylphenylsulfonyl)phenoxazine)

GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.

Required fields are marked with *

You may receive emails regarding this submission. Any emails will include the ability to opt-out of future communications.